As shown in Fig. 4J, the expression of both H3K27me3 and KRT14 increases in splenic metastatic cells compared to primary tumor cells, confirming the positive correlation between H3K27me3 and KRT14 in TNBC splenic metastasis in a preclinical animal model. Here, KRT14 is linked to neoplasm.